These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1590690)

  • 41. Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV.
    Clanton DJ; Buckheit RW; Terpening SJ; Kiser R; Mongelli N; Borgia AL; Schultz R; Narayanan V; Bader JP; Rice WG
    Antiviral Res; 1995 Aug; 27(4):335-54. PubMed ID: 8540754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro.
    Baba M; Shigeta S; Yuasa S; Takashima H; Sekiya K; Ubasawa M; Tanaka H; Miyasaka T; Walker RT; De Clercq E
    Antimicrob Agents Chemother; 1994 Apr; 38(4):688-92. PubMed ID: 7518216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective inhibition of human immunodeficiency virus type 1 replication by the (-) but not the (+) enantiomer of gossypol.
    Lin TS; Schinazi R; Griffith BP; August EM; Eriksson BF; Zheng DK; Huang LA; Prusoff WH
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2149-51. PubMed ID: 2619282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation.
    Baba M; Schols D; De Clercq E; Pauwels R; Nagy M; Györgyi-Edelényi J; Löw M; Görög S
    Antimicrob Agents Chemother; 1990 Jan; 34(1):134-8. PubMed ID: 2327749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
    Ichimura H; Levy JA
    Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1.
    Taylor DL; Ahmed PS; Chambers P; Tyms AS; Bedard J; Duchaine J; Falardeau G; Lavallée JF; Brown W; Rando RF; Bowlin T
    Antivir Chem Chemother; 1999 Mar; 10(2):79-86. PubMed ID: 10335402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retention of marked sensitivity to (S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3,4-di hydroquin oxaline-2(1H)-thione (HBY 097) by an azidothymidine (AZT)-resistant human immunodeficiency virus type 1 (HIV-1) strain subcultured in the combined presence of quinoxaline HBY 097 and 2',3'-dideoxy-3'-thiacytidine (lamivudine).
    Balzarini J; Pelemans H; Riess G; Roesner M; Winkler I; De Clercq E; Kleim JP
    Biochem Pharmacol; 1998 Mar; 55(5):617-25. PubMed ID: 9515572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The M539V polymerase variant of human hepatitis B virus demonstrates resistance to 2'-deoxy-3'-thiacytidine and a reduced ability to synthesize viral DNA.
    Ladner SK; Miller TJ; King RW
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2128-31. PubMed ID: 9687422
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication.
    Schols D; Wutzler P; Klöcking R; Helbig B; De Clercq E
    J Acquir Immune Defic Syndr (1988); 1991; 4(7):677-85. PubMed ID: 1675677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-human immunodeficiency virus and anti-hepatitis-B virus activities and toxicities of the enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine and their 5-fluoro analogues in vitro.
    Mansour TS; Jin H; Wang W; Hooker EU; Ashman C; Cammack N; Salomon H; Belmonte AR; Wainberg MA
    J Med Chem; 1995 Jan; 38(1):1-4. PubMed ID: 7837220
    [No Abstract]   [Full Text] [Related]  

  • 51. Design, enantiopure synthesis, and biological evaluation of novel iso-D-2',3'-dideoxy-3'-fluorothianucleoside derivatives as a bioisostere of lamivudine.
    Kim KR; Park AY; Moon HR; Chun MW; Jeong LS
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):911-5. PubMed ID: 18058507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. (R)-(-)- and (S)-(+)-Synadenol: synthesis, absolute configuration, and enantioselectivity of antiviral effect.
    Qiu YL; Hempel A; Camerman N; Camerman A; Geiser F; Ptak RG; Breitenbach JM; Kira T; Li L; Gullen E; Cheng YC; Drach JC; Zemlicka J
    J Med Chem; 1998 Dec; 41(26):5257-64. PubMed ID: 9857093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors.
    Buckheit RW; Fliakas-Boltz V; Decker WD; Roberson JL; Pyle CA; White EL; Bowdon BJ; McMahon JB; Boyd MR; Bader JP
    Antiviral Res; 1994 Sep; 25(1):43-56. PubMed ID: 7529014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro.
    Hayashi S; Phadtare S; Zemlicka J; Matsukura M; Mitsuya H; Broder S
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6127-31. PubMed ID: 3261865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-HIV and anti-HBV activity and resistance profile of 2',3'-dideoxy-3'-thiacytidine (3TC) and its arylphosphoramidate derivative CF 1109.
    Balzarini J; Wedgwood O; Kruining J; Pelemans H; Heijtink R; De Clercq E; McGuigan C
    Biochem Biophys Res Commun; 1996 Aug; 225(2):363-9. PubMed ID: 8753770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
    Mazumder A; Neamati N; Sommadossi JP; Gosselin G; Schinazi RF; Imbach JL; Pommier Y
    Mol Pharmacol; 1996 Apr; 49(4):621-8. PubMed ID: 8609889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potentiation of the anti-HIV activity of zalcitabine and lamivudine by a CTP synthase inhibitor, 3-deazauridine.
    Gao WY; Johns DG; Mitsuya H
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):371-7. PubMed ID: 10772721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genotypic and phenotypic characterization of HIV-1 isolated from patients receiving (--)-2',3'-dideoxy-3'-thiacytidine.
    Kavlick MF; Shirasaka T; Kojima E; Pluda JM; Hui F; Yarchoan R; Mitsuya H
    Antiviral Res; 1995 Oct; 28(2):133-46. PubMed ID: 8585767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication. 2. Effect of heteroaromatic linkers on the activity of bicyclams.
    Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Abrams MJ; Joao HC; Witvrouw M; De Vreese K; Pauwels R; De Clercq E
    J Med Chem; 1996 Jan; 39(1):109-19. PubMed ID: 8568797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.